Search Results - Gitonga, J.

Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein by Wright, D., Allen, E.R., Clark, M.H.A., Gitonga, J.N., Karanja, H.K., Hulswit, R.J.G., Taylor, I., Biswas, S., Marshall, J., Mwololo, D., Muriuki, J., Bett, Bernard K., Bowden, T.A., Warimwe, G.M.

Get full text

Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4–5 June 2024 by Gharpure, R., Vegvari, C., Abdissa, A., Alimi, Y., Anyamba, A., Auerbach, J., Bett, Bernard K., Bird, B.H., Bob, N.S., Breugelmans, J.G., Clark, J., Cleaveland, S., Cramer, J., Dawa, J., Fay, P.C., Formenty, P., Gerdts, V., Gerken, Keli N., Gitonga, J., Groschup, M., Heighway, J., Johnson, S.A.M., Juma, John, Kading, R.C., Kamau, M., Kerama, S., Lubisi, B.A., Lutwama, J., Luyimbazi, D., Marami, D., Moore, S.M., Muturi, M., Mwangoka, G., Ndiu, A., Njenga, M.K., Njouom, R., Nyakarahuka, L., Nzietchueng, S., Oloo, P., Otiende, M., Oyola, Samuel O., Paganini, L.S., Pandit, P.S., Punt, C., Samy, A.M., Situma, S., Sneddon, H., Bosch, Q.A. ten, Tezcan-Ulger, S., Thompson, P.N., Tildesley, M., Tinto, B., Vesga, J.F., Wichgers Schreur, P.P., Hart, P.

Get full text